Tackling Infectious Diseases with Special Reference to India: Need for Multidimensional Approach
Yasmeena Hassan, Ishfaq Majeed Dar, Jahangir Mohi Uddin, Sadaf Saleem, Mohd Younis Rather, Ajaz Ahmad Waza
Journal of Advances in Medicine and Medical Research · pp. 82–92 · Published 31 Jan 2024
10.9734/jammr/2024/v36i15353Abstract
Infectious diseases have long been a major cause for concern since they frequently result in pandemics. Undoubtedly, we have some degree of infection control, but the recent COVID-19 outbreak has reduced us to powerless bystanders watching people perish. The majority of infection-related deaths are caused by respiratory viral diseases, including tuberculosis. The oncovirus as a cause of cancer is a severe health issue that demands attention. The emergence of new harmful forms worsens the problem of infectious diseases. The antigenic profile of pathogens is constantly shifting, which reduces the effectiveness of vaccines or encourages the emergence of medication resistance. The necessity for an all-inclusive strategy is apparent after undertaking a thorough analysis of the scientific knowledge now in existence regarding genesis, transmission, pathophysiology, and availability, as well as the efficacy of medications against infections. There are many grey regions that require attention. For instance, we need to comprehend the biology of the diseases that new infections cause as well as the origin of those infections, the processes and factors that make some hosts vulnerable while others are resistant, the comorbid factors in a population that favours certain infections, and the potential oncogenic viruses of common cancers. We only have a few antimicrobial medicines or vaccines, and many of them are losing their efficacy daily due to bacteria' development of clever neutralizing defences. To find novel therapeutic targets, we must launch a comprehensive research effort. As an alternative, we must go the other way by utilizing passive immunity strategies or researching antiviral medicinal plant products, created chemical analogues, probiotics, and their derived bacteriocins that will demonstrate effective effects against pathogenic bacteria. The action's mechanism can then be understood. As a result, it is imperative that everyone work together to complement one another's skills in order to launch a multifaceted strategy to fill in all the knowledge gaps related to infectious diseases.
Cited by 0
No indexed citations yet.
Related research
- Systemic Antibiotic Use in Endodontic Infections: A Narrative Review — shares topic coverage
- Pathogenesis of the Influenza Virus in Diabetes Model Mice — shares topic coverage
- Comparative Analysis of Clinical and Biological Characteristics of African Swine Fever Virus Isolates from 2013 Year Russian Federation — shares topic coverage
- Prevalence and Molecular Characterization of Dral 1 gene of Schistosoma haematobium Associated with Pathogenesis of Human Urinary Schistosomiasis among School Pupils in Cross River State, Nigeria — shares topic coverage
- Temporal and Spatial Changes in Host Defense Enzymes in Response to Fusarium Wilt in Pigeonpea (Cajanus cajan (L.) Millspaugh) — shares topic coverage
Article metrics
Real usage data collected on this platform.
8
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.